We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Surgical and Trauma Wound Care Market

By HospiMedica staff writers
Posted on 20 Dec 2007
Driven by an aging population and continued advances in biotechnology, the worldwide surgical and trauma wound treatment market is expected to continue growing, according to a new report by Kalorama Information (New York, NY, USA).

With millions of surgeries performed annually worldwide, surgical and trauma wounds are, by far, the most common types of wounds addressed in the wound care area, and the aging world population has created increased demand for all types of surgical intervention, particularly cardiovascular, orthopedic, urological, and dermatological procedures. More...
Kalorama Information projects that the market will continue to expand, with further growth likely coming from new therapies and emerging technologies that decrease healing times, provide cost savings, and improve patient care.

"In order to remain competitive, manufacturers must have a clear insight into physician usage patterns and recent market movements to make perceptive business decisions,” said report author analyst Mary Anne Crandall. "Competitors that offer traditional mature products must look for ways to incorporate advanced wound care products for speeding healing with their existing products or to improve the existing products significantly to remain competitive with emerging technologies.”

According to the report, the surgical and trauma wound treatment market grew nearly 70% between 2001 and 2006 with conventional products generating the majority of sales. Kalorama Information expects that the worldwide surgical and trauma wound treatment market will post a compound annual growth rate of 5.5% and grow to US$7 billion by 2011.


Related Links:
Kalorama Information

Gold Member
12-Channel ECG
CM1200B
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Floor‑Mounted Digital X‑Ray System
MasteRad MX30+
Radiation Safety Barrier
RayShield Intensi-Barrier
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.